Arcadia Biosciences (RKDA) Invested Capital (2014 - 2025)

Arcadia Biosciences has reported Invested Capital for 12 years, with the latest figure at $4.1 million in Q4 2025.

• For the quarter ending Q4 2025, Invested Capital fell 33.47% year-over-year to $4.1 million; the trailing twelve-month figure through Dec 2025 stood at $4.1 million (down 33.47% YoY), and the FY2025 full-year result was $4.1 million, down 33.47% from the prior year.
• Invested Capital for Q4 2025 stood at $4.1 million, down from $5.4 million in the prior quarter.
• The five-year high for Invested Capital was $46.8 million in Q1 2021, with the low at $4.1 million in Q4 2025.
• Historically, Invested Capital has averaged $19.5 million across 5 years, with a median of $16.1 million in 2023.
• Annual changes were most pronounced in 2021 — Invested Capital soared 282.74% — and 2025, when it plunged 60.81%.
• Arcadia Biosciences' Invested Capital stood at $31.3 million in 2021, then tumbled by 32.99% to $20.9 million in 2022, then sank by 39.36% to $12.7 million in 2023, then slumped by 51.01% to $6.2 million in 2024, then plunged by 33.47% to $4.1 million in 2025.
• The last three Invested Capital figures came in at $4.1 million (Q4 2025), $5.4 million (Q3 2025), and $4.5 million (Q2 2025), per Business Quant data.